Beam Therapeutics Inc. (BEAM) Operating Income (Loss) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Beam Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2024.
  • Beam Therapeutics Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$104 M, a 5.26% decline year-over-year.
  • Beam Therapeutics Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$182 M, a 49.7% increase year-over-year.
  • Beam Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$176 M, a 47.9% increase from 2022.
  • Beam Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$338 M, a 13.8% increase from 2021.
  • Beam Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$392 M, a 196% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$182 M -$104 M -$5.2 M -5.26% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$176 M $133 M +$222 M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$398 M -$108 M -$17 M -18.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$381 M -$102 M -$20.2 M -24.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$361 M -$98.9 M -$22.7 M -29.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$338 M -$89 M -$25.5 M -40.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$313 M -$91.3 M -$21.7 M -31.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$291 M -$82 M -$23 M -39% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$268 M -$76.2 M +$124 M +62% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$392 M -$63.5 M -$22.7 M -55.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$370 M -$69.6 M -$32.3 M -86.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$337 M -$59 M -$32.7 M -124% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$305 M -$200 M -$172 M -607% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$133 M -$40.8 M -$14.4 M -54.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$118 M -$37.3 M -$19.3 M -107% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$99 M -$26.3 M -$8.63 M -48.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$90.4 M -$28.4 M -$15.2 M -116% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$75.2 M -$26.4 M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 -$18 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$17.7 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$13.1 M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.